New combinations and immunotherapies for melanoma: latest evidence and clinical utility

af Menzies, Alexander M., Long, Georgina V.
Udgivet 2013

Dabrafenib and its potential for the treatment of metastatic melanoma

af Menzies, Alexander M, Long, Georgina V, Murali, Rajmohan
Udgivet 2012

Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care

af Scolyer, Richard A., Long, Georgina V., Thompson, John F.
Udgivet i Mol Oncol (2011)

Reinvigorating tumour-infiltrating lymphocytes from checkpoint inhibitor resistant melanomas

af Silva, Inês Pires da, Batten, Marcel, Long, Georgina V.
Udgivet i Br J Cancer (2018)

Combined targeted therapy and immunotherapy in the treatment of advanced melanoma

af Wilmott, James S., Scolyer, Richard A., Long, Georgina V., Hersey, Peter
Udgivet 2012

Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion

af Menzies, Alexander M, Yeh, Iwei, Botton, Thomas, Bastian, Boris C., Scolyer, Richard A, Long, Georgina V
Udgivet i Pigment Cell Melanoma Res (2015)

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies

af Lee, Hansol, Da Silva, Inês Pires, Palendira, Umaimainthan, Scolyer, Richard A., Long, Georgina V., Wilmott, James S.
Udgivet i Cancers (Basel) (2021)

Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors

af Muir, Christopher Alan, Menzies, Alexander M, Clifton-Bligh, Roderick John, Long, Georgina V, Scolyer, Richard A, Tsang, Venessa
Udgivet i J Endocr Soc (2021)

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

af Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Udgivet i BMC Nephrol (2020)

Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition

af Park, John J., Diefenbach, Russell J., Byrne, Natalie, Long, Georgina V., Scolyer, Richard A., Gray, Elin S., Carlino, Matteo S., Rizos, Helen
Udgivet i Cancers (Basel) (2021)

Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF Inhibitors

af Ziemys, Arturas, Kim, Michelle, Menzies, Alexander M., Wilmott, James S., Long, Georgina V., Scolyer, Richard A., Kwong, Larry, Holder, Ashley, Boland, Genevieve
Udgivet i Front Oncol (2020)

Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma

af Menzies, Alexander M., Haydu, Lauren E., Carlino, Matteo S., Azer, Mary W. F., Carr, Peter J. A., Kefford, Richard F., Long, Georgina V.
Udgivet 2014

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series

af Carlino, Matteo S, Vanella, Vito, Girgis, Christina, Giannarelli, Diana, Guminski, Alex, Festino, Lucia, Kefford, Richard F, Menzies, Alexander M, Long, Georgina V, Ascierto, Paolo A
Udgivet i Br J Cancer (2016)

Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling

af Chien, Andy J., Haydu, Lauren E., Biechele, Travis L., Kulikauskas, Rima M., Rizos, Helen, Kefford, Richard F., Scolyer, Richard A., Moon, Randall T., Long, Georgina V.
Udgivet 2014

BRAF inhibition decreases cellular glucose uptake in melanoma in association with reduction in cell volume

af Theodosakis, Nicholas, Held, Matthew A., Marzuka-Alcala, Alexander, Meeth, Katrina M., Micevic, Goran, Long, Georgina V., Scolyer, Richard A., Stern, David F., Bosenberg, Marcus W.
Udgivet i Mol Cancer Ther (2015)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”

af Tsang, Venessa H M, McGrath, Rachel T, Clifton-Bligh, Roderick J, Scolyer, Richard A, Jakrot, Valerie, Guminski, Alexander D, Long, Georgina V, Menzies, Alexander M
Udgivet i J Clin Endocrinol Metab (2020)

Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma

af Carlino, Matteo S., Todd, Jason R., Gowrishankar, Kavitha, Mijatov, Branka, Pupo, Gulietta M., Fung, Carina, Snoyman, Stephanie, Hersey, Peter, Long, Georgina V., Kefford, Richard F., Rizos, Helen
Udgivet i Mol Oncol (2014)

Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies

af Lee, Jenny H., Long, Georgina V., Menzies, Alexander M., Lo, Serigne, Guminski, Alexander, Whitbourne, Kataraina, Peranec, Michelle, Scolyer, Richard, Kefford, Richard F., Rizos, Helen, Carlino, Matteo S.
Udgivet i JAMA Oncol (2018)

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

af Krisp, Christoph, Parker, Robert, Pascovici, Dana, Hayward, Nicholas K., Wilmott, James S., Thompson, John F., Mann, Graham J., Long, Georgina V., Scolyer, Richard A., Molloy, Mark P.
Udgivet i Br J Cancer (2018)

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

af Nahar, Kazi J, Rawson, Robert V, Ahmed, Tasnia, Tattersall, Stephen, Sandanayake, Neomal, Kiely, Christopher J, Lo, Serigne, Carlino, Matteo, Palendira, Umaimainthan, Scolyer, Richard A, Long, Georgina V, Menzies, Alexander M
Udgivet i J Immunother Cancer (2020)